NCT02244281View on ClinicalTrials.gov

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

November 30, 2003

Conditions
Lower Urinary Tract Symptoms
Interventions
DRUG

tamsulosin hydrochloride

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02244281 - Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms | Biotech Hunter | Biotech Hunter